Connection

Fengcai Zhu to Vaccines, Inactivated

This is a "connection" page, showing publications Fengcai Zhu has written about Vaccines, Inactivated.
Connection Strength

1.111
  1. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 02; 21(2):181-192.
    View in: PubMed
    Score: 0.502
  2. Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials. Chin Med J (Engl). 2021 Apr 28; 134(11):1289-1298.
    View in: PubMed
    Score: 0.129
  3. Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation. Hum Vaccin Immunother. 2018 06 03; 14(6):1517-1523.
    View in: PubMed
    Score: 0.105
  4. A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months. Expert Rev Vaccines. 2018 03; 17(3):257-262.
    View in: PubMed
    Score: 0.103
  5. Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans. Vaccine. 2017 10 09; 35(42):5644-5652.
    View in: PubMed
    Score: 0.101
  6. 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study. J Infect Dis. 2017 Jan 01; 215(1):56-63.
    View in: PubMed
    Score: 0.094
  7. A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5. Emerg Microbes Infect. 2018 Nov 21; 7(1):185.
    View in: PubMed
    Score: 0.027
  8. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China. Expert Rev Vaccines. 2017 11; 16(11):1155-1169.
    View in: PubMed
    Score: 0.025
  9. Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints. Expert Rev Vaccines. 2017 09; 16(9):945-949.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.